May 06, 2024
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
April 25, 2024
World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated
April 16, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 09, 2024
Boehringer Ingelheim Biopharmaceuticals China receives approval for supply of EU and US markets
April 06, 2024
Results announced from EMPACT-MI phase III trial
March 19, 2024
SPEVIGO® approved for expanded indications in China and the US
March 11, 2024
New partnership to develop schizophrenia treatments
February 26, 2024
Survodutide Phase II trial shows groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
February 19, 2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.
February 08, 2024
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
January 18, 2024
Global Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development
January 11, 2024